Depression
Conditions
Brief summary
The aim of the study is to evaluate the effect of 6 weeks of aerobic endurance exercise as adon treatment for moderately to severely depressed inpatients. Endpoints are symptom severity, psychological variables, cognitive symptoms, sleep, hypothalamic-pituitary-adrenal axis (HPA-axis), Brain-derived neurotrophic factor (BDNF) and heartrate variability (HRV). Amendment 1 (Nov. 2016): additional evaluation of TNF-alpha at baseline, +2 weeks and post (+6weeks) in already existing blood samples.
Detailed description
Patients are randomly assigned to the intervention group (IG) or control group (CG). The IG will train three times per week on indoor bicycles at 60 to 75% of maximal heartrate aiming at a weekly total of 17.5kcal/kg bodyweight for 6 consecutive weeks. The exercise will take place under supervision. CG will absolve a basic stretching and mobilisation program 3 times per week, also under supervision for 6 consecutive weeks. At the end of every week physical fitness is evaluated by the queens step test. No other activities with moderate or high intensity are allowed throughout the intervention time. All patients will participate in the multimodal treatment program of the depression ward, which includes pharmacotherapy, psychotherapy and specialized therapies such as art therapy and ergotherapy.
Interventions
BEHAVIORALAerobic exercise
BEHAVIORALPlacebo control
Sponsors
Psychiatric Hospital of the University of Basel
University of Basel
Solothurner Spitäler AG
University Hospital, Basel, Switzerland
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No
Inclusion criteria
* Inpatient treatment on the Depression ward * International Classification of Diseases (ICD)-10: F32, F33 or F31 * HDRS-17\>16 Points * written informed consent
Exclusion criteria
* Any physical condition that prohibits endurance exercise * 3 or more cardiovascular risk factors (hypertonia, family history, smoking, hypertriglyceridemia, diabetes) * pathological ECG * BMI \> 35 kg/m2 * Pregnancy * acute suicidal Ideation * comorbid substance dependence (except nicotine) * Major comorbid psychiatric disorder * regular high intensity exercise prior to treatment
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Depressive Symptoms self rated | Baseline (pre), 1 week, 2 weeks, 6 weeks (post), 6 months (followup) | Change in Score of Hamilton Depression Rating Scale (HDRS-17) from baseline until 6 months follow-up |
| Depressive Symptoms physician rated | Baseline (pre), 1 week, 2 weeks, 6 weeks (post), 6 months (follow-up) | Change in Score of Beck Depression Inventory (BDI) from baseline until 6 months follow-up |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Sleep (Subjective sleep Quality) | Baseline (pre), 6 weeks (post), 6 months (followup) | Change of Score of Pittsburgh sleep quality index (PSQI) from baseline until follow-up |
| Sleep (Polysomnography) | Baseline (pre), 6 weeks (post) | Change in sleep stages between baseline and follow-up |
| Cognition | Baseline (pre), 6 weeks (post), 6 months (followup) | Change in performance in Executive functions (alertness, working memory, flexibility, go/nogo, divided attention) measured by Testbatterie zur Aufmerksamkeitsprüfung (TAP) |
| Social stress - cortisol | Baseline (pre), 6 weeks (post) | Change of Salivary cortisol-course (Area under the curve) during Trier Social Stress Test (TSST) |
| Social stress - heartrate | Baseline (pre), 6 weeks (post) | Change of heartrate-course during Trier Social Stress Test (TSST) |
| Psychological symptoms | Baseline (pre), 6 weeks (post), 6 months (follow-up) | Change of scores in Symptom Checklist (SCL-90R) from baseline until follow-up |
| Cortisol awakening response (CAR) | Baseline (pre), 2 weeks, 6 weeks (post), 6 months (follow-up) | Change of Salivary cortisol increase (Area under the curve, measured at awakening, +10, +20 and +30 minutes) from baseline until 6 months follow-up |
| Physical activity | Baseline (pre), 6 months (follow-up) | Change of weekly physical activity as self reported by the International Physical Activity Questionnaire - Short Version (IPAQ-short) |
| Sleep related personality traits | Baseline (pre), 6 weeks (post), 6 months (followup) | Change in Focussing and Rumination subscores of the Fragebogen zur Erfassung von Persönlichkeitsmerkmalen Schlafgestörter (FEPS II) |
| Body Mass Index (BMI) | Baseline (pre), 6 weeks (post), 6 months (followup) | Change(BMI) |
| Resting Heartrate (HR) | Baseline (pre), 6 weeks (post), 6 months (followup) | Change of HR |
| Blood Pressure (BP) | Baseline (pre), 6 weeks (post), 6 months (followup) | Change of BP |
| TNF-Alpha (additional value assessed/Amendment 1) | Baseline (pre), 2 weeks (post), 6 weeks (post) | Change of TNF-alpha |
| Mental Toughness | Baseline (pre), 6 weeks (post), 6 months (followup) | Change in score in Mental Toughness Questionnaire (MTQ18)from baseline until follow-up |
| Brain derived neurotrophic factor (Serum-BDNF) | Baseline (pre), 2 weeks, 6 weeks (post), 6 months (followup) | Change of Serum-BDNF |
Countries
Switzerland
Outcome results
None listed